(Q34210631)

31 July 2017

title

Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival (English)

1 reference

31 July 2017

1 reference

Ana Fernández-Somoano

object named as

Ana Fernández-Somoano

4

0 references

Adonina Tardón

object named as

Adonina Tardón

6

0 references

author name string

Patricia González-Arriaga

1

1 reference

31 July 2017

Teresa Pascual

2

1 reference

31 July 2017

Arturo García-Alvarez

3

1 reference

31 July 2017

M Felicitas López-Cima

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 March 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

page(s)

121

1 reference

The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Matrix metalloproteinases and tumor metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Biomarkers in cancer staging, prognosis and treatment selection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Global cancer statistics, 2002

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

New functions for the matrix metalloproteinases in cancer progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Stabilization of lactate dehydrogenase following freeze thawing and vacuum-drying in the presence of trehalose and borate

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-121

Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350430

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma

28 October 2018

1 reference

12 December 2020

Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis

1 reference

12 December 2020

Relationship between matrix metalloproteinase 2 and lung cancer progression

1 reference

12 December 2020

Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas

1 reference

12 December 2020

Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-12-121

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference